8th Annual World Life Sciences Conference
3 Jun - 4 Jun 2022
Session information
Compulsory licensing or competition arrangements: a new way to access medicines and vaccines?
Saturday 4 June (0945 - 1120)
Committee(s)
Healthcare and Life Sciences Law Committee
(Lead)
Intellectual Property and Entertainment Law Committee
(Lead)
Technology Law Committee
(Lead)
Description
With the Covid-19 pandemic, a remarkable mobilisation of resources occurred: governments removed anti-trust restrictions and provided capital, pharmaceutical companies large and small collaborated and biotechnology companies and universities pooled knowledge. There were still regulatory roadblocks and problems of scale, but the significant scientific breakthroughs and miraculous innovations have helped combat the disease. This panel will discuss how (or if) the intellectual property or competition laws of different countries helped the innovation of new medical technologies related to Covid-19 and recent discussions and examples around business rationales, voluntary/compulsory licensing, antitrust and key contractual issues. The panel will also discuss collaborations between competitors and the panoply of contractual, IP and competition law issues.
Session / Workshop Chair(s)
| Özge Atilgan Karakulak | Gün + Partners, Istanbul, Turkey; Co-Chair, Intellectual Property and Entertainment Law Committee |
| Jason Jarvis Jardine | Knobbe Martens Olson and Bear LLP, San Diego, California, USA; Chair, Patent Law Subcommittee |
Speakers
| Fernando Arnulfo Portugal - Pescador | AMIIF, Mexico City, Mexico |
| Harry Rubin | Kramer Levin, New York, New York, USA |
| Natasha Tardif | Reed Smith, Paris, France |
| Deepa Tiku | K&S Partners, Gurgaon, Haryana, India; Vice Chair, Emerging Intellectual Property Rights Subcommittee |